Sep. 24, 2024 — Parkinson's disease, a debilitating nervous system ... 2024 — Certain drugs commonly used to treat enlarged prostate may also decrease the risk for dementia with Lewy bodies ...

Parkinson’s disease is a chronic and progressive condition affecting the brain and nervous system. It impacts millions of ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

Parkinson’s Disease (PD) is a common brain disorder that affects movement and is most often linked with aging. It’s the second most common age-related brain disease, affecting millions worldwide.

Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...

The following column was originally published on Feb. 25, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...

Early initiation of pimavanserin among patients with Parkinson disease psychosis were more likely to experience complete symptom resolution.

A drug that is commonly used to treat ... The drug may also show promise in the treatment of other neurodegenerative diseases, including Huntington's and Parkinson's. Dementia affects more than ...

With rising demand and an ageing population, European healthcare systems are under strain. In the second article in our ...

Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological ...

Common Degenerative Brain Disease May Begin to Develop in Middle ... In the future, the discovery may be used in treatment for Parkinson's ...